Docetaxel as salvage treatment for non-small cell lung cancer: Implementation study;Le docétaxel comme traitement de rattrapage pour les cancers bronchiques non à petites cellules: Étude d'implémentation

Revue Medicale de Bruxelles

Volumn 26, Issue 3, 2005, Pages 153-158

  Mascaux, C ^a,b   Iannino, N ^a   Berghmans, T ^a   Meert, A P ^a   Sculier, J P ^a  

^a JULES BORDET INSTITUTE   (Belgium)

^b FNRS   (Belgium)

Author keywords

Docetaxel; Implementation; Lung cancer

Indexed keywords

DOCETAXEL;

ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD TOXICITY; CANCER RELAPSE; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL TRIAL; FEBRILE NEUTROPENIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; INFECTION; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; LUNG TOXICITY; NEUTROPENIA; RETROSPECTIVE STUDY; SALVAGE THERAPY; STOMATITIS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TAXOIDS;

EID: 21744449065     PISSN: 00353639     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Shepherd FA, Dancey J, Ramlau R et al: Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previously treated with platinum-based chemotherapy. J Clin Oncol 2000; 18: 2095-103
2. Fossella FV, DeVore R, Kerr RN et al: Randomized phase III trial of docetaxel versus vinorelbine or ifosfamide in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens [In Process Citation]. J Clin Oncol 2000; 18: 2354-62
3. Pfister DG, Johnson DH, Azzoli CG et al: American Society of Clinical Oncology treatment of unresectable non-small cell lung cancer guideline: update 2003. J Clin Oncol 2004; 22: 330-53
4. Karnofsky DA, Abelman WH, Craver LF et al: The use of nitrogen mustard in the palliative treatment of cancer. Cancer 1948; 1: 634-56
5. Fossella FV, Lee JS, Shin DM et al: Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small cell lung cancer. J Clin Oncol 1995; 13: 645-51
6. Saarinen A, Jekunen A, Halme M et al: A phase II trial of docetaxel in advanced non-small cell lung cancer. Anticancer Drugs 1996; 7: 890-2
7. Alexopoulos CG, Rigatos G, Efremidis AP et al: A phase II study of the effectiveness of docetaxel (Taxotere) in women with advanced breast cancer previously treated with polychemotherapy. Hellenic Cooperative lnterhospital Group in Oncology. Cancer Chemother-Pharmacol 1999; 44: 253-8
8. Perng RP, Shih JF, Chen YM et al: A phase II study of single-agent docetaxel chemotherapy for non-small cell lung cancer. Jpn J Clin Oncol 2000; 30: 429-34
9. Gandara DR, Vokes E, Green M et al: Activity of docetaxel in platinum-treated non-small cell lung cancer: results of a phase II multicenter trial. J Clin Oncol 2000; 18: 131-5
10. Mattson K, Bosquee L, Dabouis G et al: Phase II study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice. Lung Cancer 2000; 29: 205-16
11. 2) as second-line monotherapy for non-small cell lung cancer. Ann Oncol 2004; 15: 38-44
12. Sumpter K, Harper-Wynne C, Yeoh C et al: Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible ? Lung Cancer 2004; 43: 369-70
13. Grol R, Cluzeau FA, Burgers JS: Clinical practice guidelines: towards better quality guidelines and increased international collaboration. Br J Cancer 2003; 89 (Suppl 1): S4-S8
14. Cauchi L, Vigus J, Diggory P: Implementation of cardiopulmonary resuscitation guidelines in elderly care departments across: a survey of 13 hospitals shows wide variability in practice. Resuscitation 2004; 63: 157-60
15. Sharkey S, Maciver S, Cameron D et al: An exploration of factors affecting the implementation of a randomized controlled trial of a transitional discharge model for people with a serious mental illness. J Psychiatr Ment Health Nurs 2005; 12: 51-6